Tricyclic

Overview of tricyclic antidepressants

Tricyclic Antidepressants

Tricyclic antidepressants (TCAs) are a class of medications that are primarily used to treat depression. They are named for their chemical structure, which contains three rings of atoms. TCAs were first discovered in the 1950s and have been used extensively in the treatment of mood disorders.

Mechanism of Action

TCAs work by inhibiting the reuptake of certain neurotransmitters in the brain, specifically norepinephrine and serotonin. By preventing the reabsorption of these neurotransmitters, TCAs increase their levels in the synaptic cleft, thereby enhancing neurotransmission and improving mood.

Common Tricyclic Antidepressants

Some of the most commonly prescribed TCAs include:

• Amitriptyline
• Nortriptyline
• Imipramine
• Desipramine
• Clomipramine

Uses

While primarily used to treat depression, TCAs are also effective in treating a variety of other conditions, including:

• Anxiety disorders
• Chronic pain
• Obsessive-compulsive disorder (OCD)
• Panic disorder
• Migraine prophylaxis

Side Effects

TCAs are associated with a range of side effects due to their non-selective action on various neurotransmitter systems. Common side effects include:

• Dry mouth
• Constipation
• Urinary retention
• Blurred vision
• Drowsiness

More serious side effects can include cardiac arrhythmias, particularly in overdose situations, and orthostatic hypotension.

Contraindications

TCAs should be used with caution in patients with certain medical conditions, such as:

• Cardiovascular disease
• Glaucoma
• Prostatic hypertrophy

Comparison with Other Antidepressants

TCAs are often compared to other classes of antidepressants, such as selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs). While TCAs are effective, they tend to have more side effects than these newer classes of medications, which has led to a decline in their use as first-line treatments.

History

The first TCA, imipramine, was discovered in the late 1950s. It was initially developed as an antipsychotic but was found to have antidepressant properties. This discovery led to the development of other TCAs and their widespread use in the treatment of depression.

Related Pages

• Antidepressant
• Selective serotonin reuptake inhibitor
• Serotonin-norepinephrine reuptake inhibitor
• Monoamine oxidase inhibitor